These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 16456233

  • 1. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1.
    Fukuda S, Kaga S, Zhan L, Bagchi D, Das DK, Bertelli A, Maulik N.
    Cell Biochem Biophys; 2006; 44(1):43-9. PubMed ID: 16456233
    [Abstract] [Full Text] [Related]

  • 2. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y, Faghihi M, Imani A, Roghani M, Zekri A, Mobasheri MB, Rastgar T, Moghimian M.
    Eur J Pharmacol; 2015 Aug 15; 761():101-8. PubMed ID: 25936512
    [Abstract] [Full Text] [Related]

  • 3. Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor.
    Penumathsa SV, Koneru S, Samuel SM, Maulik G, Bagchi D, Yet SF, Menon VP, Maulik N.
    Free Radic Biol Med; 2008 Oct 01; 45(7):1027-34. PubMed ID: 18694817
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chinese medicine GeGen-DanShen extract protects from myocardial ischemic injury through promoting angiogenesis via up-regulation of VEGF/VEGFR2 signaling pathway.
    Zhai S, Zhang XF, Lu F, Chen WG, He X, Zhang CF, Wang CZ, Yuan CS.
    J Ethnopharmacol; 2021 Mar 01; 267():113475. PubMed ID: 33068653
    [Abstract] [Full Text] [Related]

  • 12. Nitric oxide triggers delayed anesthetic preconditioning-induced cardiac protection via activation of nuclear factor-kappaB and upregulation of inducible nitric oxide synthase.
    Chen CH, Chuang JH, Liu K, Chan JY.
    Shock; 2008 Sep 01; 30(3):241-9. PubMed ID: 18708911
    [Abstract] [Full Text] [Related]

  • 13. Hypoxic preconditioning triggers myocardial angiogenesis: a novel approach to enhance contractile functional reserve in rat with myocardial infarction.
    Sasaki H, Fukuda S, Otani H, Zhu L, Yamaura G, Engelman RM, Das DK, Maulik N.
    J Mol Cell Cardiol; 2002 Mar 01; 34(3):335-48. PubMed ID: 11945025
    [Abstract] [Full Text] [Related]

  • 14. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M, Sata M, Morita T, Nakajima T, Hirata Y, Nagai R.
    Arterioscler Thromb Vasc Biol; 2010 Jul 01; 30(7):1315-24. PubMed ID: 20413734
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL, Yin H, Huang J.
    Cardiovasc Pathol; 2007 Jul 01; 16(4):221-30. PubMed ID: 17637430
    [Abstract] [Full Text] [Related]

  • 16. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T, Otani H, Yoshioka K, Fujita M, Okazaki T, Iwasaka T.
    Am J Physiol Heart Circ Physiol; 2011 Nov 01; 301(5):H2061-72. PubMed ID: 21890687
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
    Lähteenvuo JE, Lähteenvuo MT, Kivelä A, Rosenlew C, Falkevall A, Klar J, Heikura T, Rissanen TT, Vähäkangas E, Korpisalo P, Enholm B, Carmeliet P, Alitalo K, Eriksson U, Ylä-Herttuala S.
    Circulation; 2009 Feb 17; 119(6):845-56. PubMed ID: 19188502
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.